Limoneira's (LMNR) "Sell (D+)" Rating Reiterated at Weiss Ratings

Key Points

• Weiss Ratings has reiterated a "sell (D+)" rating for Limoneira (LMNR), stating ongoing concerns about the company's stock performance.
• Several analysts have varying outlooks on the stock, with ratings ranging from "strong sell" to "buy", and an average price target of $20.50.
• Limoneira's stock is currently trading at $14.72, having experienced a slight decline of 0.8% recently, with a market capitalization of $265.70 million.

Limoneira (NASDAQ:LMNR - Get Free Report)'s stock had its "sell (d+)" rating restated by stock analysts at Weiss Ratings in a report released on Wednesday,Weiss Ratings reports.

Other research analysts have also issued reports about the stock. Stephens initiated coverage on shares of Limoneira in a research report on Friday, September 12th. They issued an "equal weight" rating and a $18.00 target price for the company. Lake Street Capital raised shares of Limoneira from a "hold" rating to a "buy" rating and set a $23.00 price target for the company in a research note on Tuesday, June 10th. Roth Capital reissued a "buy" rating on shares of Limoneira in a research note on Monday, September 15th. Finally, Zacks Research lowered shares of Limoneira from a "hold" rating to a "strong sell" rating in a report on Tuesday, September 16th. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $20.50.

Limoneira Stock Down 0.8%

Shares of NASDAQ:LMNR opened at $14.72 on Wednesday. Limoneira has a 52-week low of $14.40 and a 52-week high of $29.22. The firm has a fifty day moving average of $15.41 and a 200 day moving average of $15.70. The firm has a market capitalization of $265.70 million, a PE ratio of -26.76 and a beta of 0.43. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.66 and a current ratio of 1.80.

Institutional Investors Weigh In On Limoneira

Large investors have recently added to or reduced their stakes in the stock. Global Alpha Capital Management Ltd. grew its position in shares of Limoneira by 0.4% during the 1st quarter. Global Alpha Capital Management Ltd. now owns 3,278,681 shares of the company's stock valued at $58,098,000 after acquiring an additional 14,500 shares during the period. Old West Investment Management LLC boosted its holdings in Limoneira by 1.4% in the 1st quarter. Old West Investment Management LLC now owns 439,682 shares of the company's stock worth $7,791,000 after buying an additional 5,995 shares during the period. Geode Capital Management LLC boosted its holdings in Limoneira by 5.6% in the 2nd quarter. Geode Capital Management LLC now owns 397,720 shares of the company's stock worth $6,226,000 after buying an additional 20,913 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Limoneira in the 1st quarter worth $4,487,000. Finally, Gamco Investors INC. ET AL boosted its holdings in Limoneira by 11.0% in the 2nd quarter. Gamco Investors INC. ET AL now owns 222,000 shares of the company's stock worth $3,474,000 after buying an additional 22,000 shares during the period. Institutional investors own 64.35% of the company's stock.

About Limoneira

Limoneira Company operates as an agribusiness and real estate development company in the United States and internationally. The company operates through three divisions: Agribusiness, Rental Operations, and Real Estate Development. It grows, processes, packs, markets, and sells lemons. The company also grows avocado, oranges, and specialty citrus and other crops, including Moro blood oranges, Cara Cara oranges, Valencia oranges, Minneola tangelos, Star Ruby grapefruit, pummelos, and wine grapes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.